webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Bis-PEG13-NHS ester

  CAS No.: 2221949-00-2   Cat No.: BADC-01083   Purity: ≥95% 4.5  

Bis-PEG13-NHS ester is a non-cleavable 13-unit PEG linker that can be used to synthesize antibody-conjugated drugs (ADCs).

Bis-PEG13-NHS ester

Structure of 2221949-00-2

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C38H64N2O21
Molecular Weight
884.92
Shipping
-20°C (International: -20°C)
Shipping
Store at 2-8°C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
4,7,10,13,16,19,22,25,28,31,34,37,40-Tridecaoxatritetracontanedioic acid, 1,43-bis(2,5-dioxo-1-pyrrolidinyl) ester; Bis-dPEG13-NHS ester; Di-NHS Ester-PEG13; NHS-PEG13-NHS; Bis-dPEG(R)13-NHS ester; 1,1'-[(1,43-Dioxo-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecaoxatritetracontane-1,43-diyl)bis(oxy)]di(2,5-pyrrolidinedione); 2,5-Pyrrolidinedione, 1,1'-[(1,43-dioxo-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecaoxatritetracontane-1,43-diyl)bis(oxy)]bis-
IUPAC Name
(2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[3-(2,5-dioxopyrrolidin-1-yl)oxy-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoate
Canonical SMILES
C1CC(=O)N(C1=O)OC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)ON2C(=O)CCC2=O
InChI
InChI=1S/C38H64N2O21/c41-33-1-2-34(42)39(33)60-37(45)5-7-47-9-11-49-13-15-51-17-19-53-21-23-55-25-27-57-29-31-59-32-30-58-28-26-56-24-22-54-20-18-52-16-14-50-12-10-48-8-6-38(46)61-40-35(43)3-4-36(40)44/h1-32H2
InChIKey
OVDFFVRBNAHLOH-UHFFFAOYSA-N
Density
1.27±0.1 g/cm3 (Predicted)
Solubility
10 mm in DMSO
Appearance
Pale Yellow or Colorless Oily Matter
Shelf Life
0-4°C for short term (days to weeks), or -20°C for long term (months).
Shipping
-20°C (International: -20°C)
Storage
Store at 2-8°C
Boiling Point
833.0±75.0°C (Predicted)
Form
Solid

Bis-PEG13-NHS ester, a versatile bifunctional crosslinker, finds widespread use in biochemical and biotechnological applications. Here are four key applications presented with high perplexity and burstiness:

Protein Conjugation: Bis-PEG13-NHS ester plays a pivotal role in linking proteins and peptides to various molecules like fluorescent dyes, drugs, or other biomolecules. Through its reaction with primary amines on proteins, stable amide bonds are formed, essential for the creation of targeted drug delivery systems and the analysis of protein interactions within diverse research landscapes.

Surface Modification: The compound’s utility extends to the modification of material surfaces, including nanoparticles, microbeads, and biosensors, enhancing biocompatibility and enabling specific binding interactions. By establishing a PEGylated layer, non-specific binding is mitigated, amplifying surface stability and functionality. This application holds particular significance in the advancement of diagnostic devices and biomedical implants.

Bioconjugation: Serving as a versatile linker for bioconjugation, Bis-PEG13-NHS ester facilitates the connection of antibodies, enzymes, or other biomolecules to solid supports or other entities. This linking capability is instrumental in crafting high-sensitivity assays, such as ELISA and immunoassays, where precise interactions are paramount. The resulting conjugates find application in diagnostics, therapeutic monitoring, and various bioanalytical endeavors.

Pharmaceutical Development: In the realm of drug development, Bis-PEG13-NHS ester emerges as a crucial tool for enhancing the pharmacokinetics and solubility of therapeutic molecules. Through the conjugation of drugs to PEG chains, the compound boosts drug stability and reduces immunogenicity, ultimately enhancing therapeutic efficacy. This approach proves particularly beneficial in the creation of long-lasting biopharmaceuticals and in diminishing the frequency of drug administration.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Bis-PEG1-PFP ester | Bis-PEG4-NHS ester | bis-PEG2-endo-BCN | Bis-PEG9-acid | Bis-PEG17-NHS ester | PDM3 | Norbornene-NHS | Norbornene-methyl-NHS | Bis-PEG7-acid | Bis-PEG10-NHS ester | Bis-PEG13-NHS ester
Send Inquiry
Verification code
Inquiry Basket